Mary Ann Cohen

on 9 May, 2013 6th Symposium and Tags:

A Biopsychosocial Approach to HIV-Associated Neurocognitive Disorders.

Read more

Jens Lundgren

on 9 May, 2013 6th Symposium and Tags: ,

Current Situation of Neuropsychological Problems of HIV Patients in Europe: Role of the European AIDS Clinical Society (EACS).

Read more

Daniel Podzamczer

on 9 May, 2013 6th Symposium and Tags:

Prevalence and clinical management of the neurocognitive disorders in the HIV-infected population.

Read more

Ignacio Pérez Valero

on 9 May, 2013 6th Symposium and Tags:

Incidence, Risk Factors and Neurocognitive Impact of CSF Viral Escape: Longitudinal Analysis of the CHARTER & HNRP Cohorts.

Read more

Marisol Cortés

on 9 May, 2013 6th Symposium and Tags:

Pilot study: Cognitive functioning evaluation in Spanish vertically HIV-infected children and adolescents.

Read more

Alessandro Livelli

on 9 May, 2013 6th Symposium and Tags:

Cognitive Rehabilitation Protocol in HIV/AIDS Outpatients with ANI and MND: a pilot study.

Read more

J.A. Munóz-Moreno

on 9 May, 2013 6th Symposium and Tags:

Cognitive Complaints in People with HIV in Spain: Prevalence and Related Variables.

Read more

Idil Kore

on 9 May, 2013 6th Symposium and Tags:

Neuropsychological performance in acute HIV: determinants of baseline performance and effects of immediate antiretroviral therapy

Read more

Mark Nelson

on 9 May, 2013 6th Symposium and Tags:

Switch from Efavirenz for CNS toxicity-UK experience.

Read more

Daniel Podzamczer

on 9 May, 2013 6th Symposium and Tags:

Comparative Neuropsychiatric Profile of Dolutegravir and Efavirenz after 48w in treatment naïve patients: Data from ING114467 SINGLE study.

Read more